AI & Software Platforms

As event spending soars, the gap between CMOs and CFOs widens. A new summit aims to forge a tech-driven truce with a new financial model.

RBC's mid-year outlook reveals a resilient bull market powered by stellar earnings, but warns of historical volatility as yields and election risks loom.

A new strategic partnership aims to overcome drug resistance in GI cancers by combining Lonza's advanced ADC platform with Antharis's targeted antibody expertise.

With Intel's new Panther Lake chips, ARBOR Technology is moving AI model training from the cloud to the device, promising a new era of truly adaptive automation.

BetterAge's new executive team signals a potent strategy: combining deep industry partnerships with advanced AI to scale in the competitive elder care market.

As autonomous AI agents begin to dominate internet traffic, a new cybersecurity battleground is emerging. We explore the shift to agent trust management.

Whimstay's new feature lets you book a vacation home hours before check-in, challenging hotels and solving the industry's spontaneity problem.

At VivaTech 2026, JCDecaux unveiled a bus shelter that fights heatwaves and AI-driven ads, blurring the line between public service and modern commerce.

Fulton Bank's latest CSR report details hundreds of millions in community investment. Is this just philanthropy, or a calculated strategy for lasting resilience?

A record $10M gift establishes a new research chair, honoring a titan of Canadian finance and positioning Montreal to solve the critical organ shortage.

Immuta's expanded Databricks partnership introduces a new security paradigm for autonomous AI, promising to turn a critical risk into a commercial advantage.

Beyond a simple donation, Sysco's long-term partnership with Second Harvest reveals a strategic approach to tackling Canada's dual crises of hunger and waste.

A defense tech investor's bet on a Databricks partner reveals a crucial truth: the AI revolution will be built not by algorithms alone, but by modernizing data.

As AI-powered cyberattacks escalate, Lumos has launched its 'Identity Agent Force,' an autonomous team of AI agents designed to defend the enterprise.

As AI drug discovery faces a crucial test, Terray Therapeutics hires a proven dealmaker. Can Lisa Decker translate digital promise into clinical reality?

As AI promises to revolutionize medicine, enterprises face complex challenges. A new ISG study aims to chart the critical partner ecosystem.

As Netflix preps its Q2 2026 report, investors look past subscriber numbers to the real story: the success of its ad-supported tiers and gaming bets.

The online therapy market is booming, attracting institutional capital. We dissect the growth drivers, regulatory risks, and evolving business models.

Big Pharma is pouring over $1 billion into AI to design complex drugs, trading lab guesswork for algorithms. It's a high-stakes play to fix a broken R&D model.

How a bootstrapped apparel brand that hit $150M in revenue chose a new kind of investor: a fund where 250+ elite athletes are partners, not just faces.